Skip to main content

Animations

MJFF Publications

3281 - 3290 of 8654 Results
Title
Year
  • Year
  • 2025
  • 2024
  • 2021
  • 2025
  • 2014
  • 2025
  • 2023
  • 2025
  • 2015
  • 2021
  • Summary Details
    OPEN
    Title: Exploring [11C]CPPC as a CSF1R-targeted PET imaging marker for early Parkinson’s disease severity
    Journal Name: Journal of Clinical Investigation
    Publisher: American Society for Clinical Investigation
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1172/jci186591
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Team Science Approaches to Unravel Monogenic Parkinson's Disease on a Global Scale
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1002/mds.29925
    Citation Count: 5
  • Summary Details
    OPEN
    Title: 4R-cembranoid protects neuronal cells from oxygen–glucose deprivation by modulating microglial cell activation
    Journal Name: Brain Research Bulletin
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.brainresbull.2021.12.007
    Citation Count: 9
  • Summary Details
    OPEN
    Title: Cyclic Alternating Pattern Dynamics in Individuals at Risk for Developing Parkinson's Disease
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/ana.27217
    Best OA location URL:
    Citation Count: 1
  • Summary Details
    RESTRICTED
    Title: Resistance of naturally secreted α‐synuclein to proteolysis
    Journal Name: The FASEB Journal
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1096/fj.13-245852
    Best OA location URL:
    Citation Count: 19
  • Summary Details
    OPEN
    Title: Allogeneic Bone Marrow‐Derived Mesenchymal Stem Cells for Parkinson's Disease: A Randomized Trial
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mds.70028
    Citation Count: 0
  • Summary Details
    OPEN
    Title: LINE-1 retrotransposons drive human neuronal transcriptome complexity and functional diversification
    Journal Name: Science Advances
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc, cc-by, cc-by
    DOI - Digital Object Identifier: 10.1126/sciadv.adh9543
    Citation Count: 41
  • Summary Details
    RESTRICTED
    Title: Response to letter to the Editor: The association between cigarette smoking and dementia with Lewy bodies
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2025.107895
    Best OA location URL:
    Citation Count: 0
  • Summary Details
    OPEN
    Title: A Novel Lead Design for Modulation and Sensing of Deep Brain Structures
    Journal Name: IEEE Transactions on Biomedical Engineering
    Publisher: Institute of Electrical and Electronics Engineers (IEEE)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1109/tbme.2015.2492921
    Citation Count: 38
  • Summary Details
    OPEN
    Title: A clinical, molecular genetics and pathological study of a FTDP-17 family with a heterozygous splicing variant c.823-10G>T at the intron 9/exon 10 of the MAPT gene
    Journal Name: Neurobiology of Aging
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2021.05.010
    Citation Count: 6
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.